Last update: Nov. 29, 2019
Increased level of risk
New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was Very Low Risk, is now set to Low Risk.
Level of risk reviewed on Nov. 29, 2019
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Sulfonamide with properties similar to those of sulfamethoxazole.
Used topically (dermatological and vaginal) for the treatment of susceptible infections.
Since the last update we have not found any published data on its excretion in breast milk.
The small dose and poor plasma uptake of most topical dermatological preparations make it very unlikely that significant amounts will pass into breast milk.
Vaginally it can be absorbed in variable quantity (PDR 2019). Do not use vaginally during the neonatal period and in deficit of glucose-6-phosphate dehydrogenase (AEHH2012).
Do not apply on nipple-areola so as to avoid its ingestion by the infant; alternatively clean before breastfeeding.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM